scispace - formally typeset
A

Anna Rita Migliaccio

Researcher at University of Bologna

Publications -  288
Citations -  20175

Anna Rita Migliaccio is an academic researcher from University of Bologna. The author has contributed to research in topics: Haematopoiesis & Progenitor cell. The author has an hindex of 56, co-authored 276 publications receiving 19272 citations. Previous affiliations of Anna Rita Migliaccio include Mount Sinai Hospital & New York Blood Center.

Papers
More filters
Journal ArticleDOI

GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy

TL;DR: GATA1 is indispensable mainly for erythroid and megakaryocyte differentiation and its deficiency results in apoptosis, and the current understanding of the functions of GATA1 in normal hematopoiesis and how it is altered in disease is reviewed.
Journal ArticleDOI

Long-Term Generation of Colony-Forming Cells (CFC) from CD34+ Human Umbilical Cord Blood Cells

TL;DR: The amplification potential of CD34+ cord blood cells in liquid cultures stimulated with SCF in combination with interleukin-3 (IL-3), erythropoietin (Epo) or granulocyte colony-stimulating factor (G-CSF) under serum-deprived conditions is analyzed to highlight the high proliferative and differentiative potential of cord blood stem cells.
Journal ArticleDOI

Calreticulin: Challenges Posed by the Intrinsically Disordered Nature of Calreticulin to the Study of Its Function

TL;DR: The Theory of calreticulin as an intrinsically disordered protein is illustrated and the Hypothesis that the dynamic conformational changes to which cal reticulin may be subjected by environmental cues, by promoting or restricting the exposure of its active sites, may affect its function under normal and pathological conditions is discussed.
Journal ArticleDOI

Use of a lethally irradiated major histocompatibility complex nonrestricted cytotoxic T-cell line for effective purging of marrows containing lysis-sensitive or -resistant leukemic targets

TL;DR: The present study shows that gamma-irradiated TALL-104 cells, cultured for 18 hours with marrows from healthy donors, do not impair the viability and long-term growth of committed and pluripotent hematopoietic progenitors, and indicates the strong potential of the Tall-104 cell line in future marrow purging strategies against lysis-susceptible and -resistant leukemias.